Whitehawk Therapeutics (WHWK) closed at $3.08 on November 10, 2026, down 4.3% from the previous close, on volume of 287,272 shares (30-day average 362,387).
Data as of November 10, 2026.
Oppenheimer Keeps Their Buy Rating on Whitehawk Therapeutics (WHWK)
TipRanks (Tue, 10-Nov 7:56 AM ET)
Whitehawk Therapeutics GAAP EPS of -$0.23 misses by $0.01
Seeking Alpha News (Mon, 9-Nov 8:12 AM ET)
Whitehawk Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
PRNewswire (Mon, 9-Nov 8:00 AM ET)
PRNewswire (Thu, 1-Oct 8:01 AM ET)
PRNewswire (Sun, 13-Sep 9:30 PM ET)
Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors
PRNewswire (Thu, 10-Sep 4:05 PM ET)
Whitehawk Therapeutics to Participate in Upcoming Investor Conferences
PRNewswire (Wed, 2-Sep 8:01 AM ET)
Whitehawk Therapeutics Secures $87.5M Private Placement to Extend Cash Runway Through 2028
Market Chameleon (Wed, 13-May 6:30 AM ET)
Tempus and Whitehawk Therapeutics Team Up to Drive Biomarker-Guided Cancer Drug Research
Market Chameleon (Thu, 16-Oct 5:55 AM ET)
WHWK's Collaboration with Tempus Targets Precision Oncology: Data-Driven ADC Pipeline Gets a Boost
Market Chameleon (Thu, 16-Oct 4:54 AM ET)
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.
Whitehawk Therapeutics trades on the NASDAQ stock market under the symbol WHWK.
As of November 10, 2026, WHWK stock price declined to $3.08 with 287,272 million shares trading.
WHWK has a beta of 2.46, meaning it tends to be more sensitive to market movements. WHWK has a correlation of 0.24 to the broad based SPY ETF.
WHWK has a market cap of $175.59 million. This is considered a Micro Cap stock.
Last quarter Whitehawk Therapeutics reported $0 in Revenue and -$.23 earnings per share. This beat revenue expectation by $383,330 and exceeded earnings estimates by $.01.
The top ETF exchange traded funds that WHWK belongs to (by Net Assets): IWM, VTI, VXF, IWN, VTWO.
WHWK has outperformed the market in the last year with a price return of +48.8% while the SPY ETF gained +12.9%. However, in the short term, WHWK had mixed performance relative to the market. It has underperformed in the last 3 months, returning -35.3% vs -2.8% return in SPY. But in the last 2 weeks, WHWK shares have fared better than the market returning -1.9% compared to SPY -2.0%.
WHWK support price is $3.06 and resistance is $3.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that WHWK shares will trade within this expected range on the day.
